Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization
Open Access
- 20 May 2022
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 134 (28)
Abstract
A Ru(bpy)3Cl2 photocatalyst is applied to the rapid trans to cis isomerization of a range of alkene‐containing pharmacological agents, including combretastatin A‐4 (CA‐4), a clinical candidate in oncology, and resveratrol derivatives, switching their configuration from inactive substances to potent cytotoxic agents. Selective in cellulo activation of the CA‐4 analog Res‐3M is demonstrated, along with its potent cytotoxicity and inhibition of microtubule dynamics.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (188406, 185898)
- European Molecular Biology Organization (ALTF 1015-2020)
This publication has 56 references indexed in Scilit:
- EBs Recognize a Nucleotide-Dependent Structural Cap at Growing Microtubule EndsCell, 2012
- Azobenzene Photoswitching without Ultraviolet LightJournal of the American Chemical Society, 2011
- Combretastatin A‐4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour modelBritish Journal of Pharmacology, 2010
- Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugatesNature Chemical Biology, 2010
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with OutcomeThyroid®, 2009
- Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory studyBritish Journal of Cancer, 2008
- Novel Combretastatin Analogues Endowed with Antitumor ActivityJournal of Medicinal Chemistry, 2006
- Anti‐mitotic properties of resveratrol analog (Z)‐3,5,4′‐trimethoxystilbeneBioFactors, 2006
- Vascular targeting of solid tumoursEuropean Journal of Cancer, 2000
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989